China Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories. The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC). It is developing Human fibrinogen, Immune Globulin Intravenous (Human), Human Antithrombin III (concentration), Human coagulation factor IX, Human Cytomegalovirus Immunoglobulin and Human Fibrin Sealant.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Symbol: NASDAQ:CBPO
- CUSIP: N/A
- Web: www.chinabiologic.com
Capitalization:- Market Cap: $3.11 billion
- Outstanding Shares: 27,201,000
Average Prices:- 50 Day Moving Avg: $113.47
- 200 Day Moving Avg: $110.67
- 52 Week Range: $96.99 - $137.39
P/E:- Trailing P/E Ratio: 29.60
- Foreward P/E Ratio: 19.30
- P/E Growth: 1.60
Sales & Book Value:- Annual Revenue: $347.03 million
- Price / Sales: 8.96
- Book Value: $18.48 per share
- Price / Book: 6.18
Profitability:- EBIDTA: $158.57 million
- Net Margins: 30.63%
- Return on Equity: 19.61%
- Return on Assets: 17.04%
Debt:- Current Ratio: 6.01%
- Quick Ratio: 3.98%
Misc:- Average Volume: 214,838 shs.
- Beta: 1.78
- Short Ratio: 4.84
Frequently Asked Questions for China Biologic Products (NASDAQ:CBPO)
What is China Biologic Products' stock symbol?
China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."
How were China Biologic Products' earnings last quarter?
China Biologic Products Inc (NASDAQ:CBPO) posted its quarterly earnings results on Thursday, February, 23rd. The company reported $0.95 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.84 by $0.11. The company earned $77.60 million during the quarter, compared to analyst estimates of $76.61 million. China Biologic Products had a net margin of 30.63% and a return on equity of 19.61%. The firm's revenue for the quarter was up 13.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.74 earnings per share. View China Biologic Products' Earnings History.
When will China Biologic Products make its next earnings announcement?
Where is China Biologic Products' stock going? Where will China Biologic Products' stock price be in 2017?
3 analysts have issued 1-year target prices for China Biologic Products' shares. Their predictions range from $128.00 to $135.00. On average, they anticipate China Biologic Products' stock price to reach $131.50 in the next twelve months. View Analyst Ratings for China Biologic Products.
Are investors shorting China Biologic Products?
China Biologic Products saw a increase in short interest in April. As of April 28th, there was short interest totalling 1,801,192 shares, an increase of 6.5% from the April 13th total of 1,690,750 shares. Based on an average daily trading volume, of 212,352 shares, the days-to-cover ratio is presently 8.5 days.
Who are some of China Biologic Products' key competitors?
Some companies that are related to China Biologic Products include Alnylam Pharmaceuticals (ALNY), Exelixis (EXEL), BIO-TECHNE Corp (TECH), Kite Pharma (KITE), Galapagos NV (GLPG), Opko Health (OPK), Nektar Therapeutics (NKTR), bluebird bio (BLUE), ACADIA Pharmaceuticals (ACAD), Puma Biotechnology (PBYI), Intercept Pharmaceuticals (ICPT), Intrexon Corp (XON), SAGE Therapeutics (SAGE), Juno Therapeutics (JUNO), Ultragenyx Pharmaceutical (RARE), Clovis Oncology (CLVS), Agios Pharmaceuticals (AGIO) and Ligand Pharmaceuticals (LGND).
Who owns China Biologic Products stock?
China Biologic Products' stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (6.91%), BlackRock Inc. (5.54%), Baillie Gifford & Co. (5.13%), FIL Ltd (3.23%), Hermes Investment Management Ltd. (2.32%) and Bank of New York Mellon Corp (2.07%). Company insiders that own China Biologic Products stock include David Gao, Ming Yang, Ming Yin, Sean Shao, Wenfang Liu, Wp X Biologics Llc, Zhijing Cbpo Liu and Zhijun Tong. View Institutional Ownership Trends for China Biologic Products.
Who sold China Biologic Products stock? Who is selling China Biologic Products stock?
China Biologic Products' stock was sold by a variety of institutional investors in the last quarter, including Mirae Asset Global Investments Co. Ltd., Credit Suisse AG, SPQ Asia Capital Ltd, Cornerstone Capital Management Holdings LLC., BARING ASSET MANAGEMENT Ltd, Ativo Capital Management LLC, Baillie Gifford & Co. and Envestnet Asset Management Inc.. Company insiders that have sold China Biologic Products stock in the last year include David Gao, Ming Yang, Sean Shao, Wenfang Liu, Wp X Biologics Llc and Zhijing Cbpo Liu. View Insider Buying and Selling for China Biologic Products.
Who bought China Biologic Products stock? Who is buying China Biologic Products stock?
China Biologic Products' stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Hermes Investment Management Ltd., Macquarie Group Ltd., Artisan Partners Limited Partnership, Alliancebernstein L.P., MARSHALL WACE ASIA Ltd and Marshall Wace North America L.P.. View Insider Buying and Selling for China Biologic Products.
How do I buy China Biologic Products stock?
Shares of China Biologic Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of China Biologic Products stock cost?
One share of China Biologic Products stock can currently be purchased for approximately $114.28.
MarketBeat Community Rating for China Biologic Products (NASDAQ:CBPO)These ratings are a survey of what our community members think about China Biologic Products. An outperform vote indicates that you believe the stock will outperform the S&P 500 over the long term. An underperform vote indicates that you believe the stock will underperform the S&P 500.
Earnings History for China Biologic Products (NASDAQ:CBPO)Earnings History by Quarter for China Biologic Products (NASDAQ:CBPO)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/2/2017 | | | | | | | | |
| 2/23/2017 | Q416 | $0.84 | $0.95 | $76.61 million | $77.60 million | View | N/A |  |
| 11/2/2016 | Q316 | $1.05 | $1.22 | $88.46 million | $86.50 million | View | N/A | |
| 8/4/2016 | Q216 | $1.16 | $1.10 | $87.60 million | $91.40 million | View | N/A | |
| 5/4/2016 | Q116 | $0.88 | $0.94 | $74.00 million | $85.60 million | View | N/A | |
| 2/25/2016 | Q415 | $0.55 | $0.74 | $66.77 million | $68.30 million | View | Listen | |
| 11/3/2015 | Q315 | $0.81 | $0.82 | $75.30 million | $78.80 million | View | N/A | |
| 8/5/2015 | Q215 | $0.87 | $0.99 | $71.75 million | $79.10 million | View | N/A | |
| 5/6/2015 | Q1 15 | $0.84 | $0.87 | | $70.35 million | View | N/A | |
| 11/5/2014 | Q4 14 | $0.43 | $0.48 | $63.00 million | $68.92 million | View | N/A | |
| 3/12/2014 | Q413 | $0.38 | $0.35 | $41.50 million | $42.60 million | View | N/A | |
| 11/5/2013 | Q313 | $0.42 | $0.56 | $47.20 million | $53.20 million | View | N/A | |
| 11/8/2012 | Q312 | | $0.54 | $41.30 million | $53.10 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for China Biologic Products (NASDAQ:CBPO)Current Year EPS Consensus Estimate: $5.09 EPS
Next Year EPS Consensus Estimate: $5.92 EPS
Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for China Biologic Products (NASDAQ:CBPO)Insider Ownership Percentage: 2.68%
Institutional Ownership Percentage: 69.86%
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/9/2017 | Zhijing Cbpo Liu | Insider | Sell | 7,500 | $116.49 | $873,675.00 | |
| 3/2/2017 | Sean Shao | Director | Sell | 20,000 | $100.78 | $2,015,600.00 | |
| 3/1/2017 | David Gao | CEO | Sell | 116,653 | $100.63 | $11,738,791.39 | |
| 8/15/2016 | Ming Yang | CFO | Sell | 21,092 | $124.32 | $2,622,157.44 | |
| 8/15/2016 | Wenfang Liu | Director | Sell | 2,900 | $124.32 | $360,528.00 | |
| 8/15/2016 | Zhijing Cbpo Liu | Insider | Sell | 1,968 | $124.32 | $244,661.76 | |
| 6/8/2016 | Wp X Biologics Llc | Director | Sell | 2,775,000 | $111.00 | $308,025,000.00 | |
| 5/20/2016 | Ming Yang | CFO | Sell | 13,908 | $113.64 | $1,580,505.12 | |
| 5/20/2016 | Ming Yin | VP | Sell | 19,618 | $113.64 | $2,229,389.52 | |
| 3/11/2016 | Zhijing Cbpo Liu | VP | Sell | 282 | $108.00 | $30,456.00 | |
| 3/7/2016 | Wp X Biologics Llc | Director | Sell | 4,257,000 | $107.00 | $455,499,000.00 | |
| 12/7/2015 | Zhijun Tong | Director | Sell | 15,000 | $118.33 | $1,774,950.00 | |
| 11/4/2015 | David Gao | CEO | Sell | 95,991 | $115.60 | $11,096,559.60 | |
| 11/2/2015 | David Gao | CEO | Sell | 12,891 | $112.26 | $1,447,143.66 | |
| 10/29/2015 | David Gao | CEO | Sell | 71,118 | $110.21 | $7,837,914.78 | |
| 10/26/2015 | David Gao | CEO | Sell | 59,542 | $105.22 | $6,265,009.24 | |
| 10/20/2015 | David Gao | CEO | Sell | 258 | $105.00 | $27,090.00 | |
| 10/19/2015 | David Gao | CEO | Sell | 200 | $105.03 | $21,006.00 | |
| 9/15/2015 | Ming Yang | CFO | Sell | 9,000 | $94.56 | $851,040.00 | |
| 9/15/2015 | Ming Yin | VP | Sell | 20,508 | $95.55 | $1,959,539.40 | |
| 9/14/2015 | Ming Yang | CFO | Sell | 11,304 | $97.08 | $1,097,392.32 | |
| 9/14/2015 | Wenfang Liu | Director | Sell | 2,717 | $97.02 | $263,603.34 | |
| 9/14/2015 | Zhijing Cbpo Liu | VP | Sell | 6,786 | $99.29 | $673,781.94 | |
| 6/15/2015 | Wp X Biologics Llc | Director | Sell | 2,645,000 | $100.28 | $265,240,600.00 | |
| 11/21/2014 | Zhijing Cbpo Liu | VP | Sell | 8,000 | $68.95 | $551,600.00 | |
| 11/10/2014 | Sean Shao | Director | Sell | 72,500 | $62.75 | $4,549,375.00 | |
| 11/10/2014 | Zhijing Cbpo Liu | VP | Sell | 7,500 | $62.75 | $470,625.00 | |
| 9/15/2014 | Gang Cbpo Yang | VP | Sell | 2,454 | $54.00 | $132,516.00 | |
| 9/15/2014 | Ming Yang | CFO | Sell | 6,164 | $54.00 | $332,856.00 | |
| 9/12/2014 | Ming Yin | VP | Sell | 3,073 | $54.00 | $165,942.00 | |
| 9/12/2013 | Wenfang Liu | Director | Sell | 2,524 | $25.00 | $63,100.00 | |
| 5/14/2013 | Wp X Biologics Llc | Director | Buy | 3,112,920 | $20.00 | $62,258,400.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for China Biologic Products (NASDAQ:CBPO)
Latest Headlines for China Biologic Products (NASDAQ:CBPO)
| Source: |
|
| Date | Headline |
|---|
 | China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders
finance.yahoo.com - May 19 at 9:06 PM |
 | China Biologic Products Inc (CBPO) Short Interest Update
www.americanbankingnews.com - May 19 at 8:26 PM |
| Zacks: Analysts Set $135.67 Price Target for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - May 12 at 8:52 PM |
 | China Biologic Products (CBPO) Shares Cross Below 200 DMA
www.nasdaq.com - May 11 at 4:48 PM |
| China Biologic Products Inc (CBPO) Insider Sells $873,675.00 in Stock
www.americanbankingnews.com - May 10 at 11:03 PM |
 | China Biologic Products' (CBPO) CEO David Gao on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 8 at 4:05 PM |
| Jefferies Group Comments on China Biologic Products Inc's FY2018 Earnings (CBPO)
www.americanbankingnews.com - May 8 at 11:58 AM |
| Zacks Investment Research Downgrades China Biologic Products Inc (CBPO) to Sell
www.americanbankingnews.com - May 5 at 7:38 PM |
| This Chinese Pharma Stock Has 20% Upside
finance.yahoo.com - May 5 at 2:20 AM |
| Edited Transcript of CBPO earnings conference call or presentation 4-May-17 11:30am GMT
finance.yahoo.com - May 4 at 9:20 PM |
| China Biologic Products posts 1Q profit - Yahoo Finance
finance.yahoo.com - May 4 at 4:19 PM |
| China Biologic Products posts 1Q profit
finance.yahoo.com - May 4 at 4:19 PM |
| Investor Network: China Biologic Products, Inc. to Host Earnings Call
finance.yahoo.com - May 4 at 4:19 PM |
| China Biologic Reports Financial Results for the First Quarter of 2017 - Yahoo Finance
finance.yahoo.com - May 4 at 2:14 AM |
 | BRIEF-China Biologic reports Q1 earnings per share $1.06
www.reuters.com - May 3 at 9:13 PM |
| China Biologic Reports Financial Results for the First Quarter of 2017
finance.yahoo.com - May 3 at 9:13 PM |
| $1.24 Earnings Per Share Expected for China Biologic Products Inc (CBPO) This Quarter
www.americanbankingnews.com - May 1 at 1:52 PM |
| China Biologic Products (CBPO) Receiving Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 10:54 AM |
| China Biologic Products (CBPO) Receives Media Impact Score of 0.17
www.americanbankingnews.com - April 25 at 3:58 PM |
| Brokerages Expect China Biologic Products Inc (CBPO) to Announce $1.24 EPS
www.americanbankingnews.com - April 24 at 7:56 PM |
| Favorable News Coverage Likely to Impact China Biologic Products (CBPO) Stock Price
www.americanbankingnews.com - April 22 at 12:53 PM |
| China Biologic Products to Report First Quarter of 2017 Financial Results
finance.yahoo.com - April 21 at 4:17 PM |
| CBPO Crosses Above Key Moving Average Level
www.nasdaq.com - April 19 at 1:01 PM |
| China Biologic Products (CBPO) Earning Very Favorable News Coverage, Study Shows
www.americanbankingnews.com - April 18 at 9:26 AM |
| China Biologic Products (CBPO) Receiving Favorable News Coverage, Report Shows
www.americanbankingnews.com - April 15 at 10:29 AM |
| China Biologic Products, Inc. – Value Analysis (NASDAQ:CBPO) : April 12, 2017
finance.yahoo.com - April 12 at 4:09 PM |
| Zacks: Brokerages Expect China Biologic Products Inc (CBPO) Will Post Quarterly Sales of $0.00
www.americanbankingnews.com - April 12 at 12:37 PM |
| China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : April 11, 2017
finance.yahoo.com - April 11 at 10:05 AM |
| ETFs with exposure to China Biologic Products, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 4:10 PM |
| Zacks: Brokerages Set $131.67 Price Target for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - April 6 at 8:45 PM |
| Analysts Set $131.67 Target Price for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - March 22 at 10:26 AM |
| CHINA BIOLOGIC PRODUCTS, INC. Financials
finance.yahoo.com - March 2 at 4:22 PM |
| China Biologic Products Becomes Oversold (CBPO)
www.nasdaq.com - March 1 at 10:29 AM |
| China Biologic Products' (CBPO) CEO David Gao on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 25 at 3:59 PM |
| Edited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT
finance.yahoo.com - February 24 at 9:21 PM |
| BRIEF-China Biologic Q4 adjusted non-GAAP earnings per share $0.95
www.reuters.com - February 24 at 12:42 PM |
| CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-K, Annual Report
us.rd.yahoo.com - February 24 at 12:42 PM |
 | China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016
us.rd.yahoo.com - February 24 at 12:42 PM |
| 5:07 pm China Biologic Products beats by $0.01, reports revs in-line; gudes FY17
us.rd.yahoo.com - February 24 at 12:42 PM |
| China Biologic Products Inc. Bottom Line Advances 31% In Q4 - Nasdaq
www.nasdaq.com - February 23 at 9:09 PM |
| Q4 2016 China Biologic Products Inc Earnings Release - After Market Close
biz.yahoo.com - February 23 at 4:07 PM |
| China Biologic Products to Report Fourth Quarter and Fiscal Year 2016 Financial Results
finance.yahoo.com - February 14 at 4:55 PM |
| Westpac Banking Corp Buys Alibaba Group Holding, US Silica Holdings, Arconic, Sells Edwards ...
www.nasdaq.com - February 10 at 3:48 PM |
| China Biologic Has A Wide Moat And Hedges Geographic Risk
seekingalpha.com - February 3 at 4:23 PM |
| Analysts Expect FNI Will Reach $34
www.nasdaq.com - January 24 at 4:43 PM |
| New Strong Sell Stocks for January 18th
finance.yahoo.com - January 18 at 3:17 PM |
| CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - January 6 at 4:31 PM |
| CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - January 4 at 5:11 PM |
 | China Cord Blood (CO) Shareholder Heng Ren Seeks $3.13/Share Special Dividend
www.streetinsider.com - December 15 at 9:35 PM |
| CBPO Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - December 2 at 9:34 PM |
China Biologic Products (CBPO) Chart for Sunday, May, 28, 2017
